202 related articles for article (PubMed ID: 1517464)
1. Transfusion associated graft versus host disease in an immunocompetent patient.
O'Connor NT; Mackintosh P
J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
[TBL] [Abstract][Full Text] [Related]
2. Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cells.
Suzuki K; Akiyama H; Takamoto S; Maruyama Y; Sakamaki H; Akagi K; Maeda Y; Takenaka M; Onozawa Y
Transfusion; 1992 May; 32(4):358-60. PubMed ID: 1585443
[TBL] [Abstract][Full Text] [Related]
3. Transfusion-associated graft-versus-host disease in an immunocompetent patient.
Capon SM; DePond WD; Tyan DB; Pepkowitz SH; Toyoda H; Cinman AC; Azer PC; Goldfinger D
Ann Intern Med; 1991 Jun; 114(12):1025-6. PubMed ID: 2029098
[No Abstract] [Full Text] [Related]
4. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
[TBL] [Abstract][Full Text] [Related]
5. The critical role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease in immunocompetent patients.
Otsuka S; Kunieda K; Kitamura F; Misawa K; Sasaoka I; Hirose M; Kasuya S; Saji S; Noma A
Transfusion; 1991; 31(3):260-4. PubMed ID: 2003327
[TBL] [Abstract][Full Text] [Related]
6. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
Shivdasani RA; Anderson KC
Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
[TBL] [Abstract][Full Text] [Related]
7. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease.
McMilin KD; Johnson RL
Transfus Med Rev; 1993 Jan; 7(1):37-41. PubMed ID: 8431657
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-associated graft-versus-host disease and its prevention.
Williamson LM; Warwick RM
Blood Rev; 1995 Dec; 9(4):251-61. PubMed ID: 8839400
[TBL] [Abstract][Full Text] [Related]
9. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
Benson K; Marks AR; Marshall MJ; Goldstein JD
Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
[TBL] [Abstract][Full Text] [Related]
10. Transfusion-associated graft-versus-host disease in an immunocompetent patient following cardiac surgery.
Rososhansky S; Badonnel MC; Hiestand LL; Popovsky MA; Szymanski IO
Vox Sang; 1999; 76(1):59-63. PubMed ID: 9933856
[TBL] [Abstract][Full Text] [Related]
11. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)].
Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F
Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455
[TBL] [Abstract][Full Text] [Related]
12. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
Ahya R; Douglas JG; Watson HG
Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.
Spitzer TR; Cahill R; Cottler-Fox M; Treat J; Sacher R; Deeg HJ
Cancer; 1990 Dec; 66(11):2346-9. PubMed ID: 2245390
[TBL] [Abstract][Full Text] [Related]
14. Fatal transfusion-associated graft-versus-host disease caused by blood from an unrelated donor in an immunocompetent patient.
Bell C
Transfusion; 1993 Sep; 33(9):785-6. PubMed ID: 8212127
[No Abstract] [Full Text] [Related]
15. HLA-matched blood products and posttransfusion graft-versus-host disease.
Charpentier F; Bracq C; Bonin P; Berling P; Duedari N
Transfusion; 1990; 30(9):850. PubMed ID: 2238036
[No Abstract] [Full Text] [Related]
16. Posttransfusion graft-versus-host disease in immunocompetent patients.
Brubaker DB
Transfusion; 1994 Jul; 34(7):647-8. PubMed ID: 8053045
[No Abstract] [Full Text] [Related]
17. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem.
Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD
J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801
[TBL] [Abstract][Full Text] [Related]
18. Fatal erythroderma (suspected graft-versus-host disease) after cholecystectomy. Retrospective analysis.
Otsuka S; Kunieda K; Hirose M; Takeuchi H; Mizutani Y; Nagaya M; Sato G; Kasuya S; Matsutomo K; Noma A
Transfusion; 1989; 29(6):544-8. PubMed ID: 2526400
[TBL] [Abstract][Full Text] [Related]
19. Posttransfusion graft-versus-host disease in two immunocompetent patients.
Rubeiz N; Taher A; Salem Z; Gharzuddine W; Kibbi AG
J Am Acad Dermatol; 1993 May; 28(5 Pt 2):862-5. PubMed ID: 8491882
[TBL] [Abstract][Full Text] [Related]
20. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes.
Wagner FF; Flegel WA
Transfusion; 1995 Apr; 35(4):284-91. PubMed ID: 7701545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
